Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 13 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 5539. Clear
Clear
4A
BRIDGEBIO PHARMA, INC. for BRIDGEBIO PHARMA, INC.
4th Quarter (Oct 1 - Dec 31) 2023 · California · House · Senate
Pharmacy
View → Q2
TODD STRATEGY GROUP for NOVARTIS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View → Q1
SANOFI US SERVICES INC. for SANOFI US SERVICES INC
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Trade (domestic/foreign), Taxation/Internal Revenue Code
View → Q1
TODD STRATEGY GROUP for NOVARTIS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View → Q4
SANOFI US SERVICES INC. for SANOFI US SERVICES INC
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Trade (domestic/foreign), Taxation/Internal Revenue Code
View → Q4
TODD STRATEGY GROUP for NOVARTIS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View → Q3
TODD STRATEGY GROUP for NOVARTIS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View → Q3
SANOFI US SERVICES INC. for SANOFI US SERVICES INC
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Manufacturing, Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View → Q2
SANOFI US SERVICES INC. for SANOFI US SERVICES INC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Trade (domestic/foreign), Taxation/Internal Revenue Code
View → Q2
TODD STRATEGY GROUP for NOVARTIS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Tariff (miscellaneous tariff bills), Health Issues
View → Q1
TIDAL BASIN ADVISORS, INC. for YC CONSULTING, LLC ON BEHALF OF PATIENTS RISING NOW
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $10,000.00 income
Copyright/Patent/Trademark, Defense, Health Issues, Pharmacy
View → Q1
LONG STRATEGIES, INC. for YC CONSULTING, LLC ON BEHALF OF PATIENTS RISING NOW
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $10,000.00 income
Copyright/Patent/Trademark, Defense, Health Issues, Pharmacy
View → Q1
FORBES-TATE for ALEXION PHARMACEUTICALS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $50,000.00 income
Medicare/Medicaid, Health Issues
View →

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem